Connection

David Potter to Analgesics

Back to Details
This is a "connection" page, showing publications David Potter has written about Analgesics.
David Potter
Connection Strength
0.994
Analgesics
  1. Ketamine: repurposing and redefining a multifaceted drug. Drug Discov Today. 2014 Dec; 19(12):1848-54.
    View in: PubMed
    Score: 0.419
  2. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Rev. 2005; 11(2):195-212.
    View in: PubMed
    Score: 0.214
  3. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Exp Eye Res. 2000 May; 70(5):675-82.
    View in: PubMed
    Score: 0.155
  4. Ocular action of an opioid peptide, DPDPE. J Ocul Pharmacol Ther. 1996; 12(2):131-9.
    View in: PubMed
    Score: 0.115
  5. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. J Pharmacol Exp Ther. 2004 May; 309(2):548-53.
    View in: PubMed
    Score: 0.050
  6. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. Neuropeptides. 2001 Oct-Dec; 35(5-6):232-7.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.